Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Isolated Gastric Metastases of Pancreatic Ductal Adenocarcinoma following Radical Resection-Impact of Endosonography-Guided Fine Needle Aspiration Tract Seeding

M. Loveček, P. Skalický, O. Urban, J. Tesaříková, M. Kliment, R. Psár, H. Švébišová, K. Urban, B. Mohelníková-Duchoňová, D. Klos, M. Stašek

. 2022 ; 10 (6) : . [pub] 20220612

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22016982

Grant support
NV 19-09-00088 Ministry of Health of the Czech republic
NU21-03-00499 Ministry of Health of the Czech republic

BACKGROUND: Endosonography-guided fine needle aspiration biopsy (EUS-FNA)-associated metachronous gastric seeding metastases (GSM) of pancreatic ductal adenocarcinoma (PDAC) represent a serious condition with insufficient evidence. METHODS: Retrospective analysis of PDAC resections with a curative-intent, proven pathological diagnosis of PDAC, preoperative EUS-FNA and post-resection follow-up of at least 60 months. The systematic literature search of published data was used for the GSM growth evaluation using Pearson correlation and the linear regression analyses. RESULTS: The inclusion criteria met 59/134 cases, 16 (27%) had retained needle tract (15 following distal pancreatectomy, 1 following pylorus-sparing head resection). In total, 3/16 cases (19%) developed identical solitary GSM (10-26th month following primary surgery) and were radically resected. A total of 30 published cases of PDAC GSM following EUS-FNA were identified. Lesion was resected in 20 distal pancreatectomy cases with complete information in 14 cases. A correlation between the metastasis size and time (r = 0.612) was proven. The regression coefficient b = 0.72 expresses the growth of 0.72 mm per month. CONCLUSIONS: The GSM represent a preventable and curable condition. A remarkably high number of GSM following EUS-FNA was identified, leading to follow-up recommendation of EUS-FNA sampled patients. Multimodal management (gastric resection, adjuvant chemotherapy) may prolong survival.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22016982
003      
CZ-PrNML
005      
20220720100046.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines10061392 $2 doi
035    __
$a (PubMed)35740414
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Loveček, Martin $u Department of Surgery I, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000197759643 $7 xx0078672
245    10
$a Isolated Gastric Metastases of Pancreatic Ductal Adenocarcinoma following Radical Resection-Impact of Endosonography-Guided Fine Needle Aspiration Tract Seeding / $c M. Loveček, P. Skalický, O. Urban, J. Tesaříková, M. Kliment, R. Psár, H. Švébišová, K. Urban, B. Mohelníková-Duchoňová, D. Klos, M. Stašek
520    9_
$a BACKGROUND: Endosonography-guided fine needle aspiration biopsy (EUS-FNA)-associated metachronous gastric seeding metastases (GSM) of pancreatic ductal adenocarcinoma (PDAC) represent a serious condition with insufficient evidence. METHODS: Retrospective analysis of PDAC resections with a curative-intent, proven pathological diagnosis of PDAC, preoperative EUS-FNA and post-resection follow-up of at least 60 months. The systematic literature search of published data was used for the GSM growth evaluation using Pearson correlation and the linear regression analyses. RESULTS: The inclusion criteria met 59/134 cases, 16 (27%) had retained needle tract (15 following distal pancreatectomy, 1 following pylorus-sparing head resection). In total, 3/16 cases (19%) developed identical solitary GSM (10-26th month following primary surgery) and were radically resected. A total of 30 published cases of PDAC GSM following EUS-FNA were identified. Lesion was resected in 20 distal pancreatectomy cases with complete information in 14 cases. A correlation between the metastasis size and time (r = 0.612) was proven. The regression coefficient b = 0.72 expresses the growth of 0.72 mm per month. CONCLUSIONS: The GSM represent a preventable and curable condition. A remarkably high number of GSM following EUS-FNA was identified, leading to follow-up recommendation of EUS-FNA sampled patients. Multimodal management (gastric resection, adjuvant chemotherapy) may prolong survival.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skalický, Pavel $u Department of Surgery I, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic
700    1_
$a Urban, Ondřej $u Department of Internal Medicine II-Gastroentrology and Geriatrics, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000267057912 $7 stk2008428564
700    1_
$a Tesaříková, Jana $u Department of Surgery I, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic
700    1_
$a Kliment, Martin $u Helios Kliniken Schwerin, Klinik für Gastroenterologie und Infektiologie, Wismarsche Strasse 393-397, 19055 Schwerin, Germany
700    1_
$a Psár, Róbert $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hněvotínská 976/3, 77900 Olomouc, Czech Republic
700    1_
$a Švébišová, Hana $u Department of Oncology, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic
700    1_
$a Urban, Kateřina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Hněvotínská 1333/5, 77900 Olomouc, Czech Republic
700    1_
$a Mohelníková-Duchoňová, Beatrice $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Hněvotínská 1333/5, 77900 Olomouc, Czech Republic $u Department of Oncology, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 976/3, 77900 Olomouc, Czech Republic
700    1_
$a Klos, Dušan $u Department of Surgery I, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000230974418
700    1_
$a Stašek, Martin $u Department of Surgery I, University Hospital Olomouc, I.P. Pavlova 185/6, 77900 Olomouc, Czech Republic
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 10, č. 6 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35740414 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100041 $b ABA008
999    __
$a ind $b bmc $g 1816393 $s 1168224
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 10 $c 6 $e 20220612 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
GRA    __
$a NV 19-09-00088 $p Ministry of Health of the Czech republic
GRA    __
$a NU21-03-00499 $p Ministry of Health of the Czech republic
LZP    __
$a Pubmed-20220718

Find record

Citation metrics

Archiving options